Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pflugers Archiv : European Journal of Physiology|November 3, 2020
Perfluorocarbon-based oxygen carriers: from physics to physiologyJohannes Jägers, Anna Wrobeln, Katja B Ferenz
Molecular and Cellular Biology|April 19, 2023
Hypoxia-Inducible Factor-2alpha Affects the MEK/ERK Signaling Pathway via Primary Cilia in Connection with the Intraflagellar Transport Protein 88 HomologTristan Leu, Jannik Denda, Anna Wrobeln, et al.
Artificial Cells, Nanomedicine, and Biotechnology|March 11, 2017
Functionality of albumin-derived perfluorocarbon-based artificial oxygen carriers in the Langendorff-heart <sup>†</sup>Anna Wrobeln, Klaus D Schlüter, Jürgen Linders, et al.
Life (Basel, Switzerland)|August 26, 2023
Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor Improves Leukocyte Energy Metabolism in Hereditary Hemorrhagic TelangiectasiaYves Schild, Jonah Bosserhoff, Freya Droege, et al.
Scientific Reports|April 8, 2022
Altered hypoxia inducible factor regulation in hereditary haemorrhagic telangiectasiaAnna Wrobeln, Tristan Leu, Jadwiga Jablonska, et al.
Scientific Reports|July 21, 2020
Albumin-derived perfluorocarbon-based artificial oxygen carriers can avoid hypoxic tissue damage in massive hemodilutionAnna Wrobeln, Johannes Jägers, Theresa Quinting, et al.
BMC Cancer|May 20, 2026
P53 - a new player in the metabolic adaptation of colorectal carcinoma cells under hypoxiaStefanie Saoub, Eric Metzen, Basant Kumar Thakur, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 25, 2017
Albumin-derived perfluorocarbon-based artificial oxygen carriers: A physico-chemical characterization and first in vivo evaluation of biocompatibilityAnna Wrobeln, Julia Laudien, Christoph Groß-Heitfeld, et al.
Journal of Clinical Medicine|July 13, 2024
Increased Risk for Infections and Allergic Disease in Hereditary Hemorrhagic TelangiectasiaFreya Droege, Jochem König, Karl S Lang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2022
Knockout of Factor-Inhibiting HIF (<i>Hif1an</i>) in Colon Epithelium Attenuates Chronic Colitis but Does Not Reduce Colorectal Cancer in MiceVera Schützhold, Jan Gravemeyer, Anne Bicker, et al.
Pageof 2